These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16436753)

  • 1. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
    Khan IA; Mirza ZM; Kumar A; Verma V; Qazi GN
    Antimicrob Agents Chemother; 2006 Feb; 50(2):810-2. PubMed ID: 16436753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
    Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus.
    Mirza ZM; Kumar A; Kalia NP; Zargar A; Khan IA
    J Med Microbiol; 2011 Oct; 60(Pt 10):1472-1478. PubMed ID: 21680766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.
    Khameneh B; Iranshahy M; Ghandadi M; Ghoochi Atashbeyk D; Fazly Bazzaz BS; Iranshahi M
    Drug Dev Ind Pharm; 2015 Jun; 41(6):989-94. PubMed ID: 24842547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
    Sharma S; Kumar M; Sharma S; Nargotra A; Koul S; Khan IA
    J Antimicrob Chemother; 2010 Aug; 65(8):1694-701. PubMed ID: 20525733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis.
    Jin J; Zhang J; Guo N; Feng H; Li L; Liang J; Sun K; Wu X; Wang X; Liu M; Deng X; Yu L
    J Med Microbiol; 2011 Feb; 60(Pt 2):223-229. PubMed ID: 21051548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.
    Kim MJ; Yun HJ; Kang JW; Kim S; Kwak JH; Choi EC
    J Antimicrob Chemother; 2003 Apr; 51(4):1011-6. PubMed ID: 12654771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of ciprofloxacin-susceptible community-associated meticillin-resistant Staphylococcus aureus in a neonatal unit.
    Seetulsingh P; Curtis C; Kearns AM
    J Hosp Infect; 2008 Apr; 68(4):374-5. PubMed ID: 18346816
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study on the active efflux mechanism in Staphylococcus aureus resistant to quinolone].
    Xu F; Duan DQ; Lin YG
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):403-6. PubMed ID: 15256091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
    Coskun-Ari FF; Bosgelmez-Tinaz G
    Eur J Med Res; 2008 Aug; 13(8):366-70. PubMed ID: 18952518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].
    Cui JC; Liu YN; Wang R; Liang BB; Pei F; Zheng ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1863-6. PubMed ID: 15631794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.
    Allen GP; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2004 Aug; 24(2):150-60. PubMed ID: 15288314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S; Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.